Page 349 - Read Online

Liu et al. Novel predictive and prognostic strategies of HBV-related HCC

carcinoma. J Hepatol 2011;55:1325-31. potential therapeutic targets. Nat Genet 2015;47:505-11.
62. Weng L, Du J, Zhou Q, Cheng B, Li J, Zhang D, Ling C. 71. Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato
Identification of cyclin B1 and Sec62 as biomarkers for recurrence M, Tsuji S, Donehower LA, Slagle BL, Nakamura H, Yamamoto S,
in patients with HBV-related hepatocellular carcinoma after surgical Shinbrot E, Hama N, Lehmkuhl M, Hosoda F, Arai Y, Walker K,
resection. Mol Cancer 2012;11:39. Dahdouli M, Gotoh K, Nagae G, Gingras MC, Muzny DM, Ojima H,
63. Kim SM, Leem SH, Chu IS, Park YY, Kim SC, Kim SB, Park ES, Shimada K, Midorikawa Y, Goss JA, Cotton R, Hayashi A, Shibahara
Lim JY, Heo J, Kim YJ, Kim DG, Kaseb A, Park YN, Wang XW, J, Ishikawa S, Guiteau J, Tanaka M, Urushidate T, Ohashi S, Okada
Thorgeirsson SS, Lee JS. Sixty-five gene-based risk score classifier N, Doddapaneni H, Wang M, Zhu Y, Dinh H, Okusaka T, Kokudo
predicts overall survival in hepatocellular carcinoma. Hepatology N, Kosuge T, Takayama T, Fukayama M, Gibbs RA, Wheeler DA,
2012;55:1443-52. Aburatani H, Shibata T. Trans-ancestry mutational landscape of
64. Kim BY, Suh KS, Lee JG, Woo SR, Park IC, Park SH, Han CJ, Kim hepatocellular carcinoma genomes. Nat Genet 2014;46:1267-73.
SB, Jeong S H, Yeom YI, Yang SJ, Kim CM, Cho SJ, Yoo YD, Cho 72. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis.
MH, Jang JJ, Choi DW, Lee KH. Integrated analysis of prognostic Science 2011;331:1559-64.
gene expression profiles from hepatitis B virus-positive hepatocellular 73. Wu LJ, Pan YD, Pei XY, Chen H, Nguyen S, Kashyap A, Liu J, Wu J.
carcinoma and adjacent liver tissue. Ann Surg Oncol 2012;19 Suppl Capturing circulating tumor cells of hepatocellular carcinoma. Cancer
3:S328-38. Lett 2012;326:17-22.
65. Lim HY, Sohn I, Deng S, Lee J, Jung SH, Mao M, Xu J, Wang K, 74. Sun Y F, Xu Y, Yang XR, Guo W, Zhang X, Qiu SJ, Shi RY,
Shi S, Joh JW, Choi YL, Park CK. Prediction of disease-free survival Hu B, Zhou J, Fan J. Circulating stem cell-like epithelial cell
in hepatocellular carcinoma by gene expression profiling. Ann Surg adhesion molecule-positive tumor cells indicate poor prognosis
Oncol 2013;20:3747-53. of hepatocellular carcinoma after curative resection. Hepatology
66. Kim JH, Sohn BH, Lee HS, Kim SB, Yoo JE, Park YY, Jeong W, Lee 2013;57:1458-68.
SS, Park E S, Kaseb A, Kim BH, Kim WB, Yeon JE, Byun KS, Chu 75. Schulze K, Gasch C, Staufer K, Nashan B, Lohse AW, Pantel K,
IS, Kim SS, Wang XW, Thorgeirsson SS, Luk JM, Kang KJ, Heo Riethdorf S, Wege H. Presence of EpCAM-positive circulating
J, Park YN, Lee JS. Genomic predictors for recurrence patterns of tumor cells as biomarker for systemic disease strongly correlates
hepatocellular carcinoma: model derivation and validation. PLoS Med to survival in patients with hepatocellular carcinoma. Int J Cancer
2014;11:e1001770. 2013;133:2165-71.
67. Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad 76. Tang JC, Feng YL, Guo T, Xie AY, Cai XJ. Circulating tumor DNA
I B, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, Clement in hepatocellular carcinoma: trends and challenges. Cell Biosci
B, Balabaud C, Chevet E, Laurent A, Couchy G, Letouze E, Calvo 2016;6:32.
F, Zucman-Rossi J. Integrated analysis of somatic mutations and 77. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as
focal copy-number changes identifies key genes and pathways in biomarkers in cancer patients. Nat Rev Cancer 2011;11:426-37.
hepatocellular carcinoma. Nat Genet 2012;44:694-8. 78. Chan KC, Lai PB, Mok TS, Chan HL, Ding C, Yeung SW, Lo YM.
68. Kan Z, Zheng H, Liu X, Li S, Barber TD, Gong Z, Gao H, Hao K, Quantitative analysis of circulating methylated DNA as a biomarker
Willard MD, Xu J, Hauptschein R, Rejto PA, Fernandez J, Wang G, for hepatocellular carcinoma. Clin Chem 2008;54:1528-36.
Zhang Q, Wang B, Chen R, Wang J, Lee NP, Zhou W, Lin Z, Peng 79. Wen L, Li J, Guo H, Liu X, Zheng S, Zhang D, Zhu W, Qu J, Guo
Z, Yi K, Chen S, Li L, Fan X, Yang J, Ye R, Ju J, Wang K, Estrella L, Du D, Jin X, Zhang Y, Gao Y, Shen J, Ge H, Tang F, Huang Y,
H, Deng S, Wei P, Qiu M, Wulur IH, Liu J, Ehsani ME, Zhang Peng J. Genome-scale detection of hypermethylated CpG islands in
C, Loboda A, Sung WK, Aggarwal A, Poon RT, Fan ST, Wang J, circulating cell-free DNA of hepatocellular carcinoma patients. Cell
Hardwick J, Reinhard C, Dai H, Li Y, Luk JM, Mao M. Whole- Res 2015;25:1376.
genome sequencing identifies recurrent mutations in hepatocellular 80. Villar S, Le Roux-Goglin E, Gouas D A, Plymoth A, Ferro G, Boniol
carcinoma. Genome Res 2013;23:1422-33. M, Lereau M, Bah E, Hall AJ, Wild CP, Mendy M, Norder H, van
69. Ahn SM, Jang SJ, Shim JH, Kim D, Hong SM, Sung CO, Baek D, der Sande M, Whittle H, Friesen MD, Groopman JD, Hainaut P.
Haq F, Ansari AA, Lee SY, Chun SM, Choi S, Choi HJ, Kim J, Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin
Kim S, Hwang S, Lee YJ, Lee J E, Jung WR, Jang HY, Yang E, exposure and hepatitis B virus infection. Environ Health Perspect
Sung WK, Lee NP, Mao M, Lee C, Zucman-Rossi J, Yu E, Lee HC, 2011;119:1635-40.
Kong G. Genomic portrait of resectable hepatocellular carcinomas: 81. Szymanska K, Chen J G, Cui Y, Gong Y Y, Turner P C, Villar S,
implications of RB1 and FGF19 aberrations for patient stratification. Wild C P, Parkin D M, Hainaut P. TP53 R249S mutations, exposure
Hepatology 2014;60:1972-82. to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort
70. Schulze K, Imbeaud S, Letouze E, Alexandrov LB, Calderaro J, of chronic hepatitis B virus carriers from Qidong, China. Cancer
Rebouissou S, Couchy G, Meiller C, Shinde J, Soysouvanh F, Epidemiol Biomarkers Prev 2009;18:1638-43.
Calatayud AL, Pinyol R, Pelletier L, Balabaud C, Laurent A, Blanc 82. Hosny G, Farahat N, Tayel H, Hainaut P. Ser-249 TP53 and
JF, Mazzaferro V, Calvo F, Villanueva A, Nault JC, Bioulac-Sage CTNNB1 mutations in circulating free DNA of Egyptian patients with
P, Stratton MR, Llovet JM, Zucman-Rossi J. Exome sequencing of hepatocellular carcinoma versus chronic liver diseases. Cancer Lett
hepatocellular carcinomas identifies new mutational signatures and 2008;264:201-8.

340 Hepatoma Research ¦ Volume 2 ¦ December 23, 2016